Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
3MB |
Other (Supplementary Material)
76MB |
Item Type: | Article |
---|---|
Title: | Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19 |
Creators Name: | Theobald, S.J., Simonis, A., Georgomanolis, T., Kreer, C., Zehner, M., Eisfeld, H.S., Albert, M.C., Chhen, J., Motameny, S., Erger, F., Fischer, J., Malin, J.J., Gräb, J., Winter, S., Pouikli, A., David, F., Böll, B., Koehler, P., Vanshylla, K., Gruell, H., Suárez, I., Hallek, M., Fätkenheuer, G., Jung, N., Cornely, O.A., Lehmann, C., Tessarz, P., Altmüller, J., Nürnberg, P., Kashkar, H., Klein, F., Koch, M. and Rybniker, J. |
Abstract: | Innate immunity triggers responsible for viral control or hyperinflammation in COVID-19 are largely unknown. Here we show that the SARS-CoV-2 spike protein (S-protein) primes inflammasome formation and release of mature interleukin-1β (IL-1β) in macrophages derived from COVID-19 patients but not in macrophages from healthy SARS-CoV-2 naïve individuals. Furthermore, longitudinal analyses reveal robust S-protein-driven inflammasome activation in macrophages isolated from convalescent COVID-19 patients, which correlates with distinct epigenetic and gene expression signatures suggesting innate immune memory after recovery from COVID-19. Importantly, we show that S-protein-driven IL-1β secretion from patient-derived macrophages requires non-specific monocyte pre-activation in vivo to trigger NLRP3-inflammasome signaling. Our findings reveal that SARS-CoV-2 infection causes profound and long-lived reprogramming of macrophages resulting in augmented immunogenicity of the SARS-CoV-2 S-protein, a major vaccine antigen and potent driver of adaptive and innate immune signaling. |
Keywords: | Inflammasomes, Innate Immunity, Macrophages, NLRP3, SARS-CoV-2, COVID-19, Innate Immunity, Interleukin-1beta, Pyrin Domain-Containing 3 Protein NLR Family, Coronavirus Spike Glycoprotein |
Source: | EMBO Molecular Medicine |
ISSN: | 1757-4676 |
Publisher: | EMBO Press / Wiley |
Volume: | 13 |
Number: | 8 |
Page Range: | e14150 |
Date: | 9 August 2021 |
Official Publication: | https://doi.org/10.15252/emmm.202114150 |
PubMed: | View item in PubMed |
Repository Staff Only: item control page